Chemotherapy in Treating Patients With Retinoblastoma

Completed · Phase 2

Conditions studied: Retinoblastoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with retinoblastoma.

Key facts

Study ID

NCT00002675

Run by

Memorial Sloan Kettering Cancer Center

People needed

50

Starts

1995-05-01

Expected to finish

2001-01-01

Last updated by the study team

2013-06-28

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.